Antifungal Dispensing in Denmark: Patterns Across Primary Care, Secondary Care, and Over‐the‐Counter Sectors
APMIS · 2026
DOI: 10.1111/apm.70269 ↗Kurz gefasst
Fachartikel in der Zeitschrift APMIS, 2026. Verfasst von Aditya K Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Antifungal Agents, Primary Health Care, Secondary Health Care, Nonprescription Drugs. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Fungal infections pose a significant health burden in Denmark. Increasing global antifungal use and emerging antifungal resistance underscore the need for ongoing characterization of national prescribing trends to inform antifungal stewardship. Danish Health Data Bank Medstat site was accessed to assess total antifungal dispensing in Denmark from 1996 to 2025 across primary care, secondary care (hospitals), and over‐the‐counter sectors for both topical and systemic antifungals. Over the 30‐year period, national antifungal dispensing patterns shifted substantially, with increased dispensing of azole/corticosteroid combination products in primary care (mean annual change of 0.065 g or ml per 1000 inhabitants/day), and persistent predominance of miconazole in secondary care and over‐the‐counter settings. Systemic prescribing was dominated by oral terbinafine in primary care and fluconazole in secondary care. Oral terbinafine dispensing in primary care was highest in 2009, while fluconazole dispensing peaked in 2013 in secondary care. Following peaks between 2009 and 2013, dispensing of several systemic antifungals subsequently declined, suggesting evolving prescribing patterns over time. Continued increases in azole/corticosteroid dispensing raises concerns regarding antifungal stewardship. Shifts in systemic antifungal dispensing for terbinafine and fluconazole may reflect changes in demographics, disease incidence (e.g., cancer), treatment guidelines, and clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Dermatology, Department of Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Mediprobe Research Inc., London, Ontario, Canada.
- PHOENIX Research Center, Department of Dermatology and Allergy, Herlev and Gentofte University Hospitals, Copenhagen, Denmark.
- Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Aditya K Gupta, Elizabeth M Teasell, Gregory Pellegrino, Vasiliki Economopoulos, Ditte M L Saunte
Zitieren
APA
Gupta, A. K., Teasell, E. M., Pellegrino, G., Economopoulos, V., & Saunte, D. M. L. (2026). Antifungal Dispensing in Denmark: Patterns Across Primary Care, Secondary Care, and Over‐the‐Counter Sectors. APMIS. https://doi.org/10.1111/apm.70269
Vancouver
Gupta AK, Teasell EM, Pellegrino G, Economopoulos V, Saunte DML. Antifungal Dispensing in Denmark: Patterns Across Primary Care, Secondary Care, and Over‐the‐Counter Sectors. APMIS. 2026. doi:10.1111/apm.70269
BibTeX
@article{Gupta2026,
author = {Gupta, Aditya K and Teasell, Elizabeth M and Pellegrino, Gregory and Economopoulos, Vasiliki and Saunte, Ditte M L},
title = {Antifungal Dispensing in Denmark: Patterns Across Primary Care, Secondary Care, and Over‐the‐Counter Sectors},
journal = {APMIS},
year = {2026},
doi = {10.1111/apm.70269}
}
EUVIMED